EUVIMEDEUVIMED entdecken
Crossref

Loss of TRAIP Could Attenuate the Breast Cancer Cells Development by Regulating PLSCR4 Stabilization

Zhiqiang Dong iD, Qiaoyun Chen, Fang Li, Wei Xie, Xueling Ma, Shengju Ge, Minglu Sun, Xinyu Zhao, Zhaoxiang Zhang, Wei Zhang, Dongfeng Wei iD, Shuhong Huang iD

Journal of Biochemical and Molecular Toxicology · 2026-04 · 40 (4)

DOI: 10.1002/jbt.70825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 06.04.2026. Verfasst von Zhiqiang Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Ubiquitin-Protein Ligases. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Yantai Nanshan University Youth Fund, Shandong Province Undergraduate Teaching Reform Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor receptor‐associated factor interacting protein (TRAIP) has emerged as a critical regulator of multiple oncogenic processes across various malignancies. However, its specific functional role and underlying mechanisms in breast cancer pathogenesis remain to be fully elucidated. Integrated bioinformatics analysis of TCGA and GTEx datasets was performed to assess TRAIP expression patterns. Complementary experimental validation was conducted using immunohistochemistry, qRT‐PCR, and western blot in clinical specimens. Functional characterization of TRAIP in breast cancer cells was achieved through CCK‐8 proliferation assays, colony formation analysis, transwell migration/invasion tests, wound healing experiments, and flow cytometric apoptosis detection. Mechanistic investigations employed co‐immunoprecipitation and ubiquitination assays to delineate the TRAIP‐PLSCR4 interaction, supplemented by rescue experiments to confirm functional interdependence. Consistent overexpression of TRAIP was observed in breast cancer tissues compared to normal controls. Genetic knockdown of TRAIP significantly attenuated malignant phenotypes, including: (1) reduction in cellular proliferation, (2) decrease in colony‐forming capacity, (3) reduction in migratory/invasive potential, and (4) increase in apoptosis rates (Annexin V staining). Mechanistically, TRAIP functioned as an E3 ubiquitin ligase mediating proteasomal degradation of PLSCR4 through K48‐linked polyubiquitination (co‐IP validation). Notably, PLSCR4 silencing effectively rescued the tumor‐suppressive effects of TRAIP knockdown. This study identifies a novel TRAIP/PLSCR4 regulatory axis in breast cancer pathogenesis, wherein TRAIP exerts its oncogenic function via ubiquitination‐dependent degradation of tumor‐suppressive PLSCR4. These findings position TRAIP as a promising therapeutic target for precision breast cancer interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsUbiquitin-Protein LigasesHumansFemaleCell ProliferationUbiquitinationApoptosisProtein StabilityCell MovementCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

EMTPLSCR4TRAIPbreast cancerubiquitination

Substanzen

Ubiquitin-Protein Ligases

Autor:innen und Institutionen

  • Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
  • Health College, Yantai Nanshan University, Yantai, Shandong, China.

ORCID-Profile: Zhiqiang Dong, Dongfeng Wei, Shuhong Huang

Förderung

  • Natural Science Foundation of Shandong Province
  • Yantai Nanshan University Youth Fund
  • Shandong Province Undergraduate Teaching Reform Research Project

Zitieren

APA

Dong, Z., Chen, Q., Li, F., Xie, W., Ma, X., Ge, S., Sun, M., Zhao, X., Zhang, Z., Zhang, W., Wei, D., & Huang, S. (2026). Loss of TRAIP Could Attenuate the Breast Cancer Cells Development by Regulating PLSCR4 Stabilization. Journal of Biochemical and Molecular Toxicology, 40(4). https://doi.org/10.1002/jbt.70825

Vancouver

Dong Z, Chen Q, Li F, Xie W, Ma X, Ge S, et al. Loss of TRAIP Could Attenuate the Breast Cancer Cells Development by Regulating PLSCR4 Stabilization. Journal of Biochemical and Molecular Toxicology. 2026;40(4). doi:10.1002/jbt.70825

BibTeX
@article{Dong2026,
  author = {Dong, Zhiqiang and Chen, Qiaoyun and Li, Fang and Xie, Wei and Ma, Xueling and Ge, Shengju and Sun, Minglu and Zhao, Xinyu and Zhang, Zhaoxiang and Zhang, Wei and Wei, Dongfeng and Huang, Shuhong},
  title = {Loss of TRAIP Could Attenuate the Breast Cancer Cells Development by Regulating PLSCR4 Stabilization},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {4},
  doi = {10.1002/jbt.70825}
}
Kostenlos starten →